ACTIVE HALF-LIFE
12-36 hours
CLASSIFICATION
Peptide Hormone
ACNE
No
WATER RETENTION
No
HBR
No
HEPATOTOXICITY
No
AROMATIZATION
No
MANUFACTURER
Ferring
WAREHOUSE
International Warehouse 2
SUBSTANCE
Human Menopausal Gonadotropin
,
Menogon 75IU Injection, commonly referred to as hMG, is used to address infertility in women and is also known as Menotropin. This hormone-active medication stimulates egg production in the ovaries, particularly for women experiencing ovarian failure. The injection is derived from the urine of postmenopausal women, which contains elevated levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), and other gonadotropins. Menogon 75IU is administered intramuscularly.
Potential side effects of Menogon 75IU Injection may include headaches, mood changes, fatigue, weight gain, swelling at the injection site, breast enlargement, and tenderness. A notable side effect is abdominal pain resulting from ovarian hyperstimulation syndrome (OHSS), which occurs when excessive egg production leads to swollen ovaries. There is also a risk of unintended twin conception following treatment. Before starting this medication, it's important to discuss any of the following medical conditions with your doctor:
Dosage varies based on individual needs and is tailored to each patient's requirements. For optimal results, it is recommended to time conception with intercourse within 12 to 36 hours after receiving the Menogon 75IU Injection. If the first treatment cycle is unsuccessful, it's crucial to reassess the situation. If ovulation does not occur after three cycles of treatment, consult your doctor to discuss your concerns regarding Menogon 75IU Injection.